Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Sweden Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20121
20131
20171
20192
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.1
Cephalon1
Karolinska University Hospital1
Kirsten Grønbæk1
Lund University Hospital1
Nordic MDS Group1
Sanofi1
Vastra Gotaland Region1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute8
Myelodysplastic Syndromes3
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Graft vs Host Disease1
Hematologic Neoplasms1
Leukemia, Myelomonocytic, Chronic1
Lymphoma, Large B-Cell, Diffuse1
Papillomavirus Infections1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.